60895-22-9 Usage
Uses
Used in Pharmaceutical Industry:
6beta,9-difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione is used as an anti-inflammatory agent for the treatment of various inflammatory conditions. Its application is based on its ability to regulate T cell survival, growth, and differentiation, as well as inhibit the induction of nitric oxide synthase, which plays a role in inflammation.
Used in Dermatological Applications:
In the dermatological field, 6beta,9-difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione is used as a topical medication for the treatment of skin disorders such as eczema, psoriasis, and other inflammatory skin conditions. Its potent anti-inflammatory and immunosuppressive properties make it an effective treatment option for these conditions.
Used in Ophthalmic Applications:
6beta,9-difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione is also used in the ophthalmic industry as an anti-inflammatory agent for the treatment of eye conditions such as uveitis, iritis, and other inflammatory eye disorders. Its ability to regulate immune responses and reduce inflammation makes it a valuable asset in managing these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 60895-22-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,8,9 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 60895-22:
(7*6)+(6*0)+(5*8)+(4*9)+(3*5)+(2*2)+(1*2)=139
139 % 10 = 9
So 60895-22-9 is a valid CAS Registry Number.
InChI:InChI=1/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16-,17+,19+,20+,21?,22+/m1/s1
60895-22-9Relevant academic research and scientific papers
A 17, 21 - double-hydroxy steroid derivatives of synthetic method
-
, (2018/04/02)
The invention relates to a method of preparing 17, 21-double-hydroxyl steroid derivatives by using 6, 9-substituted silyl steroid enol ether compound I as an initiator.
